Filing Details

Accession Number:
0001209191-22-038425
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-06-21 16:34:56
Reporting Period:
2022-06-16
Accepted Time:
2022-06-21 16:34:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1654151 Deciphera Pharmaceuticals Inc. DCPH Pharmaceutical Preparations (2834) 200299725
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1713712 Lee Daniel Flynn C/O Deciphera Pharmaceuticals, Inc.
200 Smith Street
Waltham MA 02451
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-06-16 1,768 $10.75 46,098 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 230,435 Indirect By Daniel L. Flynn Revocable Trust
Common Stock 91,020 Indirect By Daniel L. Flynn Irrevocable Trust
Footnotes
  1. This sale was to cover tax liabilities in the vesting of restricted stock.